封面
市场调查报告书
商品编码
1541555

生物材料市场报告(按类型(天然生物材料、金属生物材料、陶瓷生物材料、聚合生物材料)、应用(神经病学、心臟病学、骨科、伤口护理、牙科、整形外科等)和地区 2024-2032

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球生物材料市场规模达1,146亿美元。医疗保健产业的不断进步,以及心血管疾病盛行率的上升,主要推动了市场的发展。

生物材料市场分析:

主要市场驱动因素:患有肌肉骨骼疾病的人数不断增加是刺激市场的主要驱动因素之一。此外,这些材料越来越多地用于可溶解的缝合线和敷料、U形钉和伤口闭合夹子中,也是另一个重要的生长诱导因素。

主要市场趋势:聚合物合成、蛋白质和胜肽工程、分子自组装和微加工技术的多项进步是支撑市场的新兴趋势。

地理趋势:由于经常需要医疗干预的老年人口不断增加,北美在整个市场上表现出明显的主导地位。此外,研究机构数量的增加和强大的医疗基础设施正在推动区域市场的成长。

竞争格局:根据生物材料市场概况,一些知名公司包括巴斯夫SE、柏克莱先进生物材料、Carpenter Technology Corporation、Collagen Matrix Inc.、CoorsTek Inc.、Corbion NV、Dentsply Sirona、Evonik Industries AG、Johnson & Johnson、 Koninklijke DSM NV、Medtronic plc、Stryker Corporation、Victrex plc 和Zimmer Biomet 等。

挑战与机会:严格的监管框架和广泛的临床前测试正在阻碍市场。然而,在临床使用前引入更具预测性的体内和体外模型来评估生物相容性预计将在预测期内扩大市场。

生物材料市场趋势:

3D列印技术的发展

包括 3D 列印技术在内的新颖创新的引入正在改善医疗植入物和设备的设计和製造方式。此外,它们还可以生产针对患者的复杂形状,这是传统方法难以或不可能实现的。因此,这些技术在牙科、骨科、义肢等解剖精准度至关重要的领域中得到了广泛的应用。反过来,这也是生物材料市场近期利润丰厚的机会之一。例如,2024年2月,纳瓦蒂马克斯超级专科医院在孟买启用了医疗3D列印实验室,以方便高精度手术。这项开创性的设施与肿瘤学紧密结合,提供最先进的精密手术,这些手术需要在重建骨科、肿瘤学和专业牙科手术中准确、仔细地进行。此外,3D 列印技术在生物材料中的广泛集成,用于创建根据患者个体解剖结构定制的复杂医疗设备和植入物,进一步在全球范围内获得广泛关注。例如,2023年10月发表的一项研究,协助卑尔根Haukeland大学医院的职业治疗师利用3D列印和扫描技术开发个人化手部矫形器,可以减轻疼痛、最大限度地减少病情恶化、提高患者的依从性等。例如,2023 年 10 月,赢创推出了适用于众多医疗应用的植入级长丝和碳纤维增强 PEEK。此外,这些技术有助于治疗慢性疾病,预计将推动未来几年的整体生物材料市场前景。例如,2023年7月,透过与韩国生物科学与生物技术研究所、韩国机械与材料研究所以及科学资讯通讯部下属研究所联合研究,推出了全球首个3D生物列印技术,增强了自然杀伤( NK)免疫细胞的功能。

组织工程的创新

组织工程在生物材料研究中扮演重要角色。开发生物替代品以维持、恢復或改善组织功能越来越受欢迎。例如,2023年6月,OrganaBio宣布推出NeoPAC胎盘和脐带组织,专门用于加速再生医学和细胞治疗的进展。此外,透过提供仅供研究使用 (RUO) 和临床级组织,OrganaBio 鼓励研究人员挖掘出生组织的潜力,从而开发创新疗法来解决多种医疗状况。除此之外,对新型支架的需求不断增长,这些支架是经过工程设计以引起所需的细胞相互作用以促进新组织形成的材料,这也推动了市场的发展。例如,2023年6月,组织工程领先创新者之一的3DBioFibR发布了两款新的胶原纤维产品,即CollaFibR 3D和μCollaFibR支架。这些变体为组织培养和组织工程应用提供了显着的好处。此外,各个组织增加对研发活动和研究设施的投资,以实现结构和功能更精确的组织工程,这也为生物材料市场收入做出了贡献。例如,2023年1月,国家生物医学影像与生物工程研究所(NIBIB)成立了生物医学工程技术加速中心(BETA中心),这是一个新的校内研究项目,旨在加速尖端技术的验证、开发和传播。该中心重点关註生物感测、工程与合成生物学、生物医学成像、奈米材料与生物材料等多个领域。

在伤口敷料中的不断增长的应用

先进伤口敷料中越来越多地采用生物材料,因为它们有助于改善多种类型伤口(包括急性和慢性损伤)的癒合过程和结果,是一个重要的生长诱导因素。除此之外,主要参与者正在开发用于伤口护理的永续材料。例如,2024年3月,科技部科学技术高等研究院(IASST)的科学家团队推出了一种由香蕉纤维製成的环保伤口敷料材料。此外,用于製造这种创新敷料材料的所有材料均来自当地且天然,使得製造过程具有成本效益、简单且无毒。除此之外,人们对基于生物材料的伤口敷料的日益青睐正在提高生物材料的市场价格。它们可以由各种材料製成,包括泡沫、水凝胶、薄膜等,这些材料通常充满抗菌剂等生物活性物质,以减少感染并促进组织再生。例如,2022 年 5 月,瑞典医疗器材新创公司 Amferia AB 获得美国专利商标局 (USPTO) 授予的基于两亲性抗菌水凝胶的抗菌材料的基础专利。与此一致的是,根据发表在《生物材料进展杂誌》上的研究结果,贝尔法斯特女王大学的一组研究人员于2023 年6 月设计了一种3D 列印绷带,也称为支架,它提供了一种创新的治疗方法来治癒糖尿病足溃疡(DFU)。

全球生物材料市场细分:

IMARC Group提供了市场各个细分市场的主要趋势的分析,以及 2024-2032 年全球、区域和国家层面的生物材料市场预测。我们的报告根据类型和应用程式对市场进行了分类。

按类型划分:

天然生物材料

金属生物材料

陶瓷生物材料

高分子生物材料

目前,金属生物材料占据最大的市场份额

该报告根据类型提供了详细的市场细分和分析。这包括天然生物材料、金属生物材料、陶瓷生物材料和聚合生物材料。根据该报告,金属生物材料代表了最大的细分市场。

此细分市场的成长是由于金属生物材料所表现出的卓越强度、最佳耐用性和增强的生物相容性而推动的。因此,他们发现了广泛的承重应用,包括牙科植入物、骨科植入物、心血管装置等。其创新的UltraThineer材料。此外,不銹钢、钛、钴铬合金等多种金属因其优异的机械性能而被广泛使用,这些金属性能可确保在身体运动压力下的使用寿命和弹性。例如,2022 年 1 月,根据《Colloids and Surfaces A》杂誌报道,研究人员用奈米多孔 TiO2 有效修饰了 TC26 合金,以增强人工植入物的骨整合和生物活性。除此之外,2023年6月,莫斯科经济特区科技城宣布生产钛植入物。因此,不断增加的产品应用将在未来几年继续推动金属生物材料市场需求。

按应用划分:

神经病学

心臟病学

骨科

伤口护理

牙科

整型手术

其他的

该报告根据应用程式提供了详细的市场细分和分析。这包括神经病学、心臟病学、骨科、伤口护理、牙科、整形外科等。

耐用的陶瓷、金属和聚合物材料对于关节置换和骨修復至关重要。此外,它们也被用于製造需要与口腔组织具有高相容性和强度的重建装置。除此之外,包括神经病学和心臟病学在内的关键领域需要用于神经植入、脑机介面、支架、心律调节器等的生物材料。奎斯特生物医学创新研究所的研究人员和加州大学洛杉矶分校开发了新型生物材料来促进新生血管并针对中风后免疫反应。根据生物材料市场统计数据,另一类包括药物输送系统和眼科等其他应用,其中生物材料分别为植入物和受管制药物释放提供量身定制的解决方案。

按地区划分:

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美目前主导全球市场份额

市场研究报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,北美占据了最大的生物材料市场。

北美有利的监管环境,特别是美国食品和药物管理局(FDA)的作用,支持新生物材料和医疗器材的快速批准和开发,正在推动该地区市场的发展。例如,2019 年 11 月,DiFusion Inc. 的 Xiphos-ZF 脊椎椎间装置获得 FDA 批准,该装置基于不同的生物材料 Zfuze(钛和聚醚醚酮的组合)。此外,2023年10月,生物材料平台公司之一Dimension Inx宣布FDA核准首款3D列印再生骨移植产品CMFlex。此外,越来越多的门诊手术中心(ASC)进行脊椎手术是另一个重要的成长诱导因素。例如,2023 年 2 月,根据 Becker 的医疗保健资料显示,美国有超过 183 个 ASC 进行微创脊椎手术 (MISS)。除此之外,整容手术的日益普及进一步刺激了区域市场。此外,包括美国国家科学基金会和美国国家标准与技术研究所在内的多个公共和私人组织发起的倡议,为生物材料的使用提供帮助,预计将在预测期内推动北美市场的发展。

本报告回答的关键问题

  • 2023年全球生物材料市场规模有多大? 2024-2032年全球生物材料市场的预期成长率是多少?
  • 推动全球生物材料市场的关键因素是什么?
  • COVID-19 对全球生物材料市场有何影响?
  • 全球生物材料市场按类型划分是怎样的?
  • 全球生物材料市场的重点区域有哪些?
  • 谁是全球生物材料市场的主要参与者/公司?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球生物材料市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章:市场区隔:按类型

  • 天然生物材料
    • 市场趋势
    • 市场预测
  • 金属生物材料
    • 市场趋势
    • 市场预测
  • 陶瓷生物材料
    • 市场趋势
    • 市场预测
  • 高分子生物材料
    • 市场趋势
    • 市场预测

第 7 章:市场区隔:按应用

  • 神经病学
    • 市场趋势
    • 市场预测
  • 心臟病学
    • 市场趋势
    • 市场预测
  • 骨科
    • 市场趋势
    • 市场预测
  • 伤口护理
    • 市场趋势
    • 市场预测
  • 牙科
    • 市场趋势
    • 市场预测
  • 整型手术
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章:市场区隔:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分:按国家/地区
    • 市场预测

第 9 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章:价值链分析

第 11 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章:价格分析

第13章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BASF SE
    • Berkeley Advanced Biomaterials
    • Carpenter Technology Corporation
    • Collagen Matrix Inc.
    • CoorsTek Inc.
    • Corbion NV
    • Dentsply Sirona
    • Evonik Industries AG
    • Johnson & Johnson
    • Koninklijke DSM NV
    • Medtronic plc
    • Stryker Corporation
    • Victrex plc
    • Zimmer Biomet
Product Code: SR112024A5892

The global biomaterials market size reached US$ 114.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 276.6 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.

Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.

Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.

Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.

Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the biomaterials market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type and application.

Breakup by Type:

Natural Biomaterial

Metallic Biomaterial

Ceramic Biomaterial

Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. According to the report, metallic biomaterial represented the largest segmentation.

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

Neurology

Cardiology

Orthopedics

Wound Care

Dental

Plastic Surgery

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

BASF SE

Berkeley Advanced Biomaterials

Carpenter Technology Corporation

Collagen Matrix Inc.

CoorsTek Inc.

Corbion N.V.

Dentsply Sirona

Evonik Industries AG

Johnson & Johnson

Koninklijke DSM N.V.

Medtronic plc

Stryker Corporation

Victrex plc

Zimmer Biomet

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Biomaterials Market Recent Developments:

February 2024: 3D Systems, one of the U.S.-based 3D printer manufacturers, launched its new multi-material 3D printed denture offering.

February 2024: Researchers from MIT introduced a 3D-printable tissue adhesive that demonstrates superior tissue adhesion. This technology holds immense potential for enhancing biomedical devices and wound care applications.

January 2024: Evonik introduced the world's first carbon-fiber-reinforced PEEK filament for long-term 3D-printed medical implants.

January 2024: restor3d, one of the musculoskeletal implant specialists, successfully commercialized femoral implants produced via a previously cleared additive manufacturing method, outperforming the mechanical properties of cast implants.

Key Questions Answered in This Report

  • 1. What was the size of the global biomaterials market in 2023?
  • 2. What is the expected growth rate of the global biomaterials market during 2024-2032?
  • 3. What are the key factors driving the global biomaterials market?
  • 4. What has been the impact of COVID-19 on the global biomaterials market?
  • 5. What is the breakup of the global biomaterials market based on type?
  • 6. What are the key regions in the global biomaterials market?
  • 7. Who are the key players/companies in the global biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomaterials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Natural Biomaterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metallic Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ceramic Biomaterial
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Polymeric Biomaterial
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Orthopedics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wound Care
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Dental
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Plastic Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 BASF SE
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Berkeley Advanced Biomaterials
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Carpenter Technology Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Collagen Matrix Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 CoorsTek Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Corbion N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Dentsply Sirona
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evonik Industries AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Johnson & Johnson
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke DSM N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Stryker Corporation
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Victrex plc
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Zimmer Biomet
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomaterials Market: Major Drivers and Challenges
  • Figure 2: Global: Biomaterials Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biomaterials Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biomaterials Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Biomaterials Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Biomaterials Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Biomaterials (Natural Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Biomaterials (Natural Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Biomaterials (Metallic Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biomaterials (Metallic Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biomaterials (Ceramic Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biomaterials (Ceramic Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biomaterials (Polymeric Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biomaterials (Polymeric Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biomaterials (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biomaterials (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biomaterials (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biomaterials (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biomaterials (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biomaterials (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biomaterials (Wound Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biomaterials (Wound Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biomaterials (Dental) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biomaterials (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biomaterials (Plastic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biomaterials (Plastic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biomaterials (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biomaterials (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Biomaterials Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Biomaterials Industry: SWOT Analysis
  • Figure 79: Global: Biomaterials Industry: Value Chain Analysis
  • Figure 80: Global: Biomaterials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomaterials Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biomaterials Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Biomaterials Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biomaterials Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biomaterials Market: Competitive Structure
  • Table 6: Global: Biomaterials Market: Key Players